1. Acton, R. T., and Barger, B. O., 1980 The potential use of HLA to predict risk of malignant diseases and outcome of therapy, in: Pediatric Oncology( G. B. Humphrey, L. P. Dehner, and G. B. Grindey, eds.), pp. 47–77, Martin Nijhoff, The Hague.
2. Acton, R. T., Barger, B. O., Murphy, C. C., Roseman, J. M., Ingalls, A. L., and Balch, C. M., 1980, Apparent association of HLA antigens with melanoma; Proc. Am. Assoc. Cancer Res. 21:49.
3. Albert, E., Amos, D. B., Bodmer W. F., Ceppellini, R., Dausset, J., Kissmeyer-Nielsen, F. Mayr, W., Payne, R., van Rood, J. J., Terasaki, P. I., and Walford, R. L., 1980, Nomenclature for factors of the HLA system 1980; Tissue Antigens 16: 113.
4. Amos, D. B., Bashir, H., Boyle, W., MacQueen, M., and Tijlikainen, F., 1970, A simple microcytotoxicity test; Transplantation 7: 220.
5. Anders, F., Diehl, H., Schwab, M., and Anders, A., 1979, Contributions to an understanding of the cellular origin of melanoma in the Gordon-Kosswig Xiphophorine fish tumor system, Pigm. Cell 4: 142.